BioSpace News Archive

Immuno-oncology is considered a promising new treatment for detecting and destroying tumors, giving cancer patients hope of a longer life

The rising demand for blood banks is one of the critical reasons that will drive the hematology analyzers and reagents market growth.

Biotechnology and healthcare companies are focusing on the development of new technologies and products to analyze the molecular level of blood group typing.

Applied StemCell is excited to announce the recent publication of A System for Site-specific Integration of Transgenes in Mammalian Cells in PLOS ONE.

Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that the Centers for Medicare and Medicaid Services (CMS) has assigned a specific and permanent reimbursement J-code, through the Healthcare Common Procedure Coding System (HCPCS) for DEXTENZA

AbbVie (NYSE:ABBV) announced financial results for the second quarter ended June 30, 2019.

Hologic’s (Nasdaq: HOLX) Cynosure division announced today the launch of two new products that expand the Company’s growing portfolio of innovative aesthetic treatments — the TempSure® Firm handpiece and a petite mask for SculpSure® submental treatments

KBL Merger Corp. IV (NASDAQ: KBLM) (“KBLM”), a Special Purpose Acquisition Company (SPAC), announced today that it has executed a definitive business combination agreement for the merger of a wholly owned subsidiary of KBLM with CannBioRx Life Sciences Corp.

Montrium, today announces that Orphazyme, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, has chosen to extend Montrium’s eTMF Connect and RegDocs Connect solutions with Quality Connect to empower end-to-end commercialization processes.

The Lange Law Firm, PLLC has been retained to investigate the Florida Cyclospora outbreak.